Selvita

Selvita company information, Employees & Contact Information

Updated June 2026

Quick answer

Selvita is a Biotechnology Research company and founded in 2007. It has approximately 782 employees on record. Contact data was last refreshed in June 2026. Find Selvita's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development.

Company Details

Employees
782
Founded
2007
Address
Podole 79, Kraków,lesser Poland Voivodeship 30-394,poland
Phone
+48 12 297 47 00
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Kraków, Lesser Poland Voivodeship
Looking for a particular Selvita employee's phone or email?

Selvita Questions

News

Drug Discovery Services Company Evaluation Report 2025 | LabCorp, Evotec, and Selvita Lead with Comprehensive Research and Laboratory Services - Yahoo Finance

Drug Discovery Services Company Evaluation Report 2025 | LabCorp, Evotec, and Selvita Lead with Comprehensive Research and Laboratory Services Yahoo Finance

Recent uptick might appease Selvita S.A. (WSE:SLV) institutional owners after losing 40% over the past year - simplywall.st

Recent uptick might appease Selvita S.A. (WSE:SLV) institutional owners after losing 40% over the past year simplywall.st

Now available on the German Market: Selvita - Cigar Journal

Now available on the German Market: Selvita Cigar Journal

Selvita S.A. (WSE:SLV) Stock Catapults 25% Though Its Price And Business Still Lag The Industry - simplywall.st

Selvita S.A. (WSE:SLV) Stock Catapults 25% Though Its Price And Business Still Lag The Industry simplywall.st

Translational pathology in drug discovery - Frontiers

Translational pathology in drug discovery Frontiers

Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24 - European Medical Journal

Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24 European Medical Journal

Selvita's growth continues with completion of new Krakow HQ - Fierce Biotech

Selvita's growth continues with completion of new Krakow HQ Fierce Biotech

Selvita epigenetic project is the first Polish drug target program selected by EU Lead Factory - researchgate.net

Selvita epigenetic project is the first Polish drug target program selected by EU Lead Factory researchgate.net

Poland: Selvita expands capabilities with completion of PozLab acquisition - Investors in Healthcare

Poland: Selvita expands capabilities with completion of PozLab acquisition Investors in Healthcare

Poland’s Selvita to split into two listed companies - The Pharma Letter

Poland’s Selvita to split into two listed companies The Pharma Letter

Selvita to cash in €90m in Menarini deal - European Biotechnology Magazine

Selvita to cash in €90m in Menarini deal European Biotechnology Magazine

Is Selvita (WSE:SLV) Using Too Much Debt? - simplywall.st

Is Selvita (WSE:SLV) Using Too Much Debt? simplywall.st

Selvita appoints new Chief Medical Officer - European Biotechnology Magazine

Selvita appoints new Chief Medical Officer European Biotechnology Magazine

Top Selvita Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant